TY - JOUR
T1 - Case report
T2 - Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel CARD14 mutation
AU - Niedzwiedz, Michal
AU - Narbutt, Joanna
AU - Siekierko, Aleksandra
AU - Skibinska, Malgorzata
AU - Kwiek, Bartlomiej
AU - Sobolewska-Sztychny, Dorota
AU - Ciazynska, Magdalena
AU - Poznanska-Kurowska, Katarzyna
AU - Gostynski, Antoni
AU - Lesiak, Aleksandra
PY - 2024/2/5
Y1 - 2024/2/5
N2 - CARD14 (caspase activation and recruitment domain) mutations have been associated with psoriasis vulgaris, psoriatic arthritis, generalized and palmoplantar pustular psoriasis, pityriasis rubra pilaris, and atopic dermatitis. We present a pediatric patient with a novel CARD14: c.394A > T/- (Ile123Phe) mutation, diagnosed with CARD14-associated papulosquamous eruption (CAPE), who was successfully treated with biological treatment.
AB - CARD14 (caspase activation and recruitment domain) mutations have been associated with psoriasis vulgaris, psoriatic arthritis, generalized and palmoplantar pustular psoriasis, pityriasis rubra pilaris, and atopic dermatitis. We present a pediatric patient with a novel CARD14: c.394A > T/- (Ile123Phe) mutation, diagnosed with CARD14-associated papulosquamous eruption (CAPE), who was successfully treated with biological treatment.
KW - CARD14
KW - CAPE
KW - biologics
KW - adalimumab
KW - ustekinumab
KW - case report
KW - CARD14: c.394A > T/- (Ile123Phe)
KW - CARD14-associated papulosquamous eruption
KW - PSORIASIS
U2 - 10.3389/fmed.2024.1360248
DO - 10.3389/fmed.2024.1360248
M3 - Article
SN - 2296-858X
VL - 11
JO - Frontiers in medicine
JF - Frontiers in medicine
M1 - 1360248
ER -